Analysis on Effects of Comprehensive Nursing Care Applied in Interventional Therapy for Patients with Liver Cirrhosis and Liver Cancer
Background: This study aimed to investigate the effects of comprehensive nursing intervention in interventional therapy for patients with liver cirrhosis and liver cancer.
Methods: Overall, 512 liver cirrhosis patients complicated with liver cancer receiving interventional therapy in the Department of Oncology of the Second Hospital of Dalian Medical University (Dalian, China) from March 2010 to March 2016 were retrospectively analyzed. Patients were divided into observation group (n=310) and control group (n=202). Comprehensive nursing intervention was applied to observation group and conventional nursing care was applied to control group.
Results: The degrees of satisfaction before and after nursing intervention, quality-of-life scores, incidences of postoperative complications and survival rates at 20 months after operation of the two groups were compared. The degree of great satisfaction in observation group was significantly higher than that in control group (P<0.001). The quality-of-life scores of the patients in observation group were obviously higher than those in control group (P<0.001). The incidence of postoperative complications in observation group was significantly lower than that in control group (P<0.001). The survival rates in observation group was significantly higher than that in control group (P=0.035).
Conclusion: The application of comprehensive nursing intervention in the interventional therapy for liver cirrhosis and liver cancer can notably improve the life quality of the patients, lower the incidence of postoperative complications and increase the survival rate, which is worthy of clinical popularization and application.
2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014). Projecting cancer incidence and deaths to 2030: the unexpected bur-den of thyroid, liver, and pancreas can-cers in the United States. Cancer Res, 74: 2913-2921.
3. Oishi N, Yamashita T, Kaneko S (2014). Molecular biology of liver cancer stem cells. Liver Cancer 3: 71-84.
4. Yoshimoto S, Loo TM, Atarashi K et al (2013). Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature, 499: 97-101.
5. Nordlinger B, Sorbye H, Glimelius B et al (2008). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup tri-al 40983): a randomised controlled trial. Lancet, 371: 1007-1016.
6. Ni CY, Yang Y, Chang YQ, Cai H, Xu B, Yang F, Lau WY, Wang ZH, Zhou WP (2013). Fast-track surgery improves post-operative recovery in patients undergoing partial hepatectomy for primary liver can-cer: A prospective randomized controlled trial. Eur J Surg Oncol, 39: 542-547.
7. Oldhafer KJ, Donati M, Jenner RM, Stang A, Stavrou GA (2014). ALPPS for pa-tients with colorectal liver metastases: ef-fective liver hypertrophy, but early tumor recurrence. World J Surg, 38: 1504-1509.
8. Mise Y, Sakamoto Y, Ishizawa T, Kaneko J, Aoki T, Hasegawa K, Sugawara Y, Ko-kudo N (2013). A worldwide survey of the current daily practice in liver surgery. Liver Cancer, 2: 55-66.
9. Abdalla EK, Bauer TW, Chun YS, D'Angeli-ca M, Kooby DA, Jarnagin WR (2013). Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus state-ments. HPB (Oxford), 15: 119-130.
10. Ahmed M, Solbiati L, Brace CL et al (2014). Image-guided tumor ablation: standardi-zation of terminology and reporting crite-ria--a 10-year update. Radiology, 273: 241-260.
11. Hayes J, Peruzzi PP, Lawler S (2014). Mi-croRNAs in cancer: biomarkers, func-tions and therapy. Trends Mol Med, 20: 460-469.
12. Fehrenbacher L, Capra AM, Quesenberry CP, Jr., Fulton R, Shiraz P, Habel LA (2014). Distant invasive breast cancer re-currence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer di-agnosed from 2000 to 2006: a cohort from an integrated health care delivery system. J Clin Oncol, 32: 2151-2158.
13. van Hoeve J, de Munck L, Otter R, de Vries J, Siesling S (2014). Quality improvement by implementing an integrated oncological care pathway for breast cancer patients. Breast, 23: 364-370.
14. K Devitt B, Philip J, McLachlan SA (2013). Re: Tumor boards and the quality of can-cer care. J Natl Cancer Inst, 105: 1838.
15. Bulechek GM, McCloskey JC (1995). Nurs-ing interventions classification (NIC). Me-dinfo, 8 Pt, 2: 1368.
16. Futier E, Marret E, Jaber S (2014). Periop-erative positive pressure ventilation: an in-tegrated approach to improve pulmonary care. Anesthesiology, 121: 400-408.
17. Keegan TH, Kurian AW, Gali K et al (2015). Racial/ethnic and socioeconomic differ-ences in short-term breast cancer survival among women in an integrated health system. Am J Public Health, 105: 938-946.
18. Daly B, Olopade OI (2015). A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin, 65: 221-238.
19. Chan DK, Zhang X, Fung HH, Hagger MS (2015). Does emotion and its daily fluctu-ation correlate with depression? A cross-cultural analysis among six developing countries. J Epidemiol Glob Health, 5: 65-74.
20. Kmiecik J, Poli A, Brons NH, Waha A, Eide GE, Enger PO, Zimmer J, Chekenya M (2013). Elevated CD3+ and CD8+ tu-mor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosup-pressive mechanisms in the tumor mi-croenvironment and at the systemic level. J Neuroimmunol, 264: 71-83.
21. Pires NM, Dong T, Hanke U, Hoivik N (2013). Integrated optical microfluidic bi-osensor using a polycarbazole photode-tector for point-of-care detection of hormonal compounds. J Biomed Opt, 18: 097001.
22. Ho J, Ahlers SM, Stratman C et al (2014). Can Digital Pathology Result In Cost Savings? A Financial Projection for Digi-tal Pathology Implementation At A Large Integrated Health Care Organization. J Pathol Inform, 5: 33.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.